Evaluation of serum procalcitonin as a significant marker in cases of septic arthritis and osteomyelitis: a two year study
Keywords:Procalcitonin, MRSA, Klebsiella, C - reactive protein
Background: Acute bone infections like septic arthritis and osteomyelitis are a serious threat in management and diagnosis in the department of orthopaedics. Biochemical marker is needed with good sensitivity and specificity in diagnosing acute bone and joint infections. The aim of the present study was to study the role of PCT in conditions of septic arthritis and osteomyelitis.
Methods: A two year prospective study was done and cases were grouped into three group and laboratory parameters TC, ESR, CRP and PCT were measured. The sensitivity, specificity and predictive values were compared using SPSS software version 20.
Results: 238 patients, (males- 154 & Females– 84) with mean age 34.1±8.20 years. Group-1 included 52 patients with raised PCT and MRSA and Klebsiella as the common isolates. Group-2 with 89 patients and mean PCT in the study group was 4.99 ng/ml. Ninety seven were included in Group-3. The mean PCT value was 2.6 ng/ml. In group-1, the specificity of PCT (comparing Group-1 & 3) was 96.8 [95% CI, 94.2 -98.4], the sensitivity (26% [3.2-60.1], the PPV 16.1% [95% CI 2.3-48.3] and the NPV was 98% [95% CI, 95.5-99.8].
Conclusions: To conclude our study, highlights the role of PCT as a sensitive and specific marker in diagnosing cases of septic arthritis and Osteomyelitis. This opens a gateway to further research in evaluating the PCT effectiveness as a response marker to treatment. PCT is more sensitive than CRP in acute bone and joint bacterial infections and raises early and faster.
Dlabach JA, Park AL. Infectious arthritis. In: Canale ST, Beaty JH. Campbell’s Operative Orthopaedics.11th edition. Philadelphia: Mosby Elsevier; 2008: 723-750.
Barresi A, Pallotti F, d'Eril GVM. Biological variation of procalcitonin in healthy individuals. Clin Chem. 2004;50:1878.
Lelubre C, Anselin S, Zouaoui Boudjeltia K, Biston P, Piagnerelli M. Interpretation of C-reactive protein concentrations in critically ill patients. Biomed Res Int. 2013;24021.
Zhao J, Zhang S, Zhang L, Dong X, Li J, Wang Y, et al. Serum procalcitonin levels as a diagnostic marker for septic arthritis: A meta-analysis. Am J Emerg Med. 2017;35(8):1166-71.
Shen CJ, Wu MS, Lin KH, Lin WL, Chen HC, Wu JY, Lee MC, Lee CC. The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2013;32(6):807-14.
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-8.
Christ-Crain M, Muller B. Procalcitonin – You only find what you look for, and you only look for what you know. JAGS. 2006;54(3):546.
Crain M, Muller B. Procalcitonin in bacterial infections– hype, hope, more or less? Swiss Med Wkly. 2005;135:451–60.
Mathews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial septic arthritis in adults. Lancet. 2010;37(5):846–55.
Li SF, Cassidy C, Chang C, Gharib S, Torres J. Diagnostic utility of laboratory tests in septic arthritis. Emerg Med J. 2007;24(2):75-7.
Butbul-Aviel Y, Koren A, Halevy R, Sakran W. Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis. Pediatr Emerg Care. 2005;21(12):828-3.
Hügle T, Schuetz P, Mueller B, Laifer G, Tyndall A, Regenass C. Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin Exp Rheumatol. 2009;26(3):453-6.
Delevaux, I, André M, Colombier M, Albuisson E, Meylheuc F, Bègue R.J. Can Procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62(4):337–40.
Faesch S, Cojocaru B, Hennequin C, Pannier S, Glorion C, Lacour B, et al. Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective trial. Ital J Pediatr. 2009;35 (1):1-6.